Agile Therapeutics (AGRX) Reports Q3 Loss, Lags Revenue Estimates

Published on November 2, 2021

Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 5.26% and -13.62%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the...